NovMetaPharma Co., Ltd. (XKON:229500)
South Korea
· Delayed Price · Currency is KRW
13,720
+240 (1.78%)
At close: Dec 5, 2025
NovMetaPharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2014 | FY 2013 |
| Dec '25 Dec 4, 2025 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
| Asset Turnover | 0.33 | 0.33 | - |
| Inventory Turnover | 3.01 | 3.01 | - |
| Quick Ratio | 28.62 | 28.62 | 18.32 |
| Current Ratio | 32.26 | 32.26 | 26.50 |
| Return on Equity (ROE) | 10.84% | 10.84% | - |
| Return on Assets (ROA) | -1.96% | -1.96% | - |
| Return on Capital (ROIC) | -2.05% | -2.05% | - |
| Return on Capital Employed (ROCE) | -2.30% | -2.30% | 2.10% |
| Buyback Yield / Dilution | - | -21.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.